CRA was retained by the plaintiff in a patent dispute to determine the amount of reasonable royalties due as a result of infringement of a patent by a major medical device company. CRA’s intellectual property expert evaluated the economic and technological comparability of multiple license agreements, the feasibility of non-infringing alternatives, and the Georgia-Pacific factors to determine the appropriate reasonable royalty rate. Dr. Sean Sheridan submitted an expert report and provided testimony in deposition. The case settled prior to trial.
CRA recognized in Chambers 2026 for litigation support and crisis & risk management
Charles River Associates has been recognized in the 2026 Chambers Litigation Support and Crisis & Risk Management Guides, including a Band 1 global ranking...